Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...
At the 64th ASMS Conference, Bruker introduces rapifleX™, the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX ...
LONDON-- (BUSINESS WIRE)--At the 22 nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces a collaboration with UMCG within the new European Network ...
This video shows Daniel Kolarich from Max Planck Institute explaining new method for improved analysis of glycans and glycoproteins. Bruker’s rapifleX TM MALDI Tissuetyper TM system can be used for ...
Bruker Corporation (NASDAQ: BRKR) today announced that it has received clearance from the China Food and Drug Administration (CFDA) to market and sell its IVD MALDI Biotyper System as a medical device ...
MONTREAL--(BUSINESS WIRE)-- At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), the companies i2A Canada and Bruker Ltd. announced ...
Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...
Bruker announced a technology acquisition in support of its microbiology business and its world-leading MALDI Biotyper microbial identification platform. Financial details were not disclosed. Bruker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback